ROBERT H. HOPKINS
Professor
Also affiliated: Tulane University (2015); American Academy of Family Physicians (2008); Centers for Disease Control and Prevention (2016); Leeds General Infirmary (1978); Aeras (2018–2020); University of Minnesota (2008); Pennsylvania State University (2008–2015); Desmond Tutu HIV Foundation (2018); University of Kansas (2013); Thomas Jefferson University (1972); University of Cape Town (2018–2020); Lehigh University (1959); Vanderbilt University (2016); VA Palo Alto Health Care System (2008); University of Arkansas Medical Center (2008); Tulane Medical Center (1999); RCA (United States) (1980); Southampton General Hospital (2023); Raigmore Hospital (1975); Edinburgh Royal Infirmary (1971–1985); Royal Hampshire County Hospital (1978); American College of Physicians (2008–2013); Allstate (United States) (1991); VA West Los Angeles Medical Center (2013); South African Tuberculosis Vaccine Initiative (2018–2020); National Foundation for Infectious Diseases (2016); AHR (United Kingdom) (2021); Arkansas State Department of Human Services (1998); Dulwich Community Hospital (1987); Arkansas Foundation for Medical Care (1998–2009); University of Southampton (2023); Institute of Infectious Disease and Molecular Medicine (2018–2020); Penn State Health Children's Hospital (2015); Case Western Reserve University (2016); University at Buffalo, State University of New York (2015); University of Missouri (2008); University of Pennsylvania (1959–2008); University of California, Davis (1965–1966); Scottish National Blood Transfusion Service (1976–1981); University of Sheffield (2004–2010); Stanford University (2008); McMaster University (2008)
Internal Med, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Robert H. Hopkins is a Professor in the Department of Internal Medicine at the University of Arkansas for Medical Sciences College of Medicine. He leads a research group and has a scholarly h-index of 19, with 309 total publications cited 2,594 times. His recent research has focused on clinical practice guidelines, including those for the prevention of tuberculosis infection, the pharmacologic treatment of dementia, and the screening, monitoring, and treatment of chronic kidney disease. He has also published on osteoporosis screening in men, managing "problem residents" in medical training, and inpatient glycemic control. His work has been published as recently as 2026, indicating continued activity in his field.
Research Overview
Currently not accepting new patients. Robert Hopkins Jr.
Metrics
- h-index: 19
- Publications: 308
- Citations: 2,593
Positions
-
Professor publications 1998–2026University of Arkansas for Medical Sciences Internal Med, College of Medicine Institutional directory
Selected Publications
-
The Importance of the Childhood Immunization Schedule for Internal Medicine (2026)
-
The U.S. Advisory Committee on Immunization Practices: Public Health in the Crosshairs (2025)
-
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic (2024)
-
Congenital Inferior Vena Cava Atresia Presenting as Extensive Thrombosis in Adulthood (2018)
-
Effective Immunization of Older Adults Against Seasonal Influenza (2018)
-
Reinvigorating Influenza Prevention in US Adults Aged 65 Years and Older (2016)
-
Benchmarks for Support and Outcomes for Internal Medicine-Pediatrics Residency Programs: A 5-Year Review (2015)
-
Immunization guidelines in the United States: New vaccines and new recommendations for children, adolescents, and adults (2013)
-
Challenges with Continuity Clinic and Core Faculty Accreditation Requirements (2013)
-
Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians (2013)
Grants & Funding
As listed on this researcher's institutional profile.
- Improving Pneumococcal Immunization of Adults with Immunocompromising Conditions Pfizer, Inc. Co-Investigator
Collaboration Network
Top Collaborators
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
- Effective Immunization of Older Adults Against Seasonal Influenza
- Immunization guidelines in the United States: New vaccines and new recommendations for children, adolescents, and adults
- Reinvigorating Influenza Prevention in US Adults Aged 65 Years and Older
- Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians
- Screening for Osteoporosis in Men: A Clinical Practice Guideline from the American College of Physicians
- Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians
- Screening for Osteoporosis in Men: A Clinical Practice Guideline from the American College of Physicians
- “Problem Residents”: Prevalence, Problems and Remediation in the Era of Core Competencies
- Challenges with Continuity Clinic and Core Faculty Accreditation Requirements
- “Problem Residents”: Prevalence, Problems and Remediation in the Era of Core Competencies
- Challenges with Continuity Clinic and Core Faculty Accreditation Requirements
- Childhood immunization: national, state rates still short of goal.
- School entry immunization: 15% of students lack complete vaccination protection.
- Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians
- Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
Similar Researchers
Based on overlapping research topics